GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52B
Enterprise Value 31.82B
Trailing P/E 48.80
Forward P/E 133.38
PEG Ratio (5 yr expected) 12.67
Price/Sales (ttm)4.89
Price/Book (mrq)6.96
Enterprise Value/Revenue 34.45
Enterprise Value/EBITDA 639.28

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 10.35%
Operating Margin (ttm)9.10%

Management Effectiveness

Return on Assets (ttm)7.34%
Return on Equity (ttm)17.39%

Income Statement

Revenue (ttm)410.26M
Revenue Per Share (ttm)11.36
Quarterly Revenue Growth (yoy)17.40%
Gross Profit (ttm)269.19M
EBITDA 46.44M
Net Income Avi to Common (ttm)42.45M
Diluted EPS (ttm)1.11
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)205.96M
Total Cash Per Share (mrq)5.56
Total Debt (mrq)58.38M
Total Debt/Equity (mrq)20.28
Current Ratio (mrq)5.67
Book Value Per Share (mrq)7.77

Cash Flow Statement

Operating Cash Flow (ttm)66.61M
Levered Free Cash Flow (ttm)39.86M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.07
52-Week Change 337.37%
S&P500 52-Week Change 34.92%
52 Week High 392.18
52 Week Low 338.23
50-Day Moving Average 361.97
200-Day Moving Average 370.42

Share Statistics

Avg Vol (3 month) 3554.7k
Avg Vol (10 day) 3472.73k
Shares Outstanding 537.07M
Float 24.6M
% Held by Insiders 12.77%
% Held by Institutions 186.93%
Shares Short (Apr 30, 2019) 42.84M
Short Ratio (Apr 30, 2019) 45.31
Short % of Float (Apr 30, 2019) 410.63%
Short % of Shares Outstanding (Apr 30, 2019) 47.66%
Shares Short (prior month Mar 29, 2019) 42.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A